Furthermore, we demonstrated that ufmylation on UFBP1 K267 was crucial for ameliorating NAFLD phenotypes, including obesity, liver steatosis, hepatic lipogenesis, dyslipidemia, insulin resistance and liver damage. This evidence concerns the gene DDRGK1 and obesity disorder.